Biote Corp BTMD

$1.07 +0.04 (3.40%)

Valuation

Market cap
37,005,000
Revenue TTM
$192,220,000
Net income TTM
$27,050,000
P/E (trailing)
8.38
P/E (forward)
19.82
Profit margin
14.07%
Debt to equity
-2.09

Trading

Volume
65,300
Avg volume
120,970
Day's range
$1.00 – $1.09
Shares out
35,927,000
Stochastic %K
30%
Beta
1.73
Analysts
Moderate Buy
Price target
$2.22

Price

Company profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components develo...

Show more

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
844 604 1246
Website
https://www.biote.com
Address
1875 W. Walnut Hill Ln #100, Irving, United States

Latest news

No headlines yet.

Stocktwits

d_risk Nov 9, 10:37 PM
$BTMD - biote Corp. - 10-Q - Updated Risk Factors Biote warns its amended Truist credit agreement contains covenants that could limit how it operates. #riskfactors #secfilings 🟢 Added 🟠 Removed https://d-risk.ai/BTMD?filing=JLQkU2wxfMpIDL0k645lU
0 replies
d_risk Nov 9, 10:36 PM
$BTMD - biote Corp. - 10-Q - Updated Legal Disclosure Biote says it paid the remaining $4.3M due under its settlement agreements in October. #legaldisclosure #secfilings 🟢 Added 🟠 Removed https://d-risk.ai/BTMD?filing=JLQkU2wxfMpIDL0k645lU#legal-filing-comparison
0 replies
glorrel Nov 5, 10:05 AM
$BTMD rip :/
1 replies
EarningsInsider Nov 4, 10:46 PM
https://www.marketbeat.com/earnings/reports/2026-11-4-haymaker-acquisition-corp-iii-stock/ $BTMD biote Earnings Transcript
0 replies
StocktwitsEarnings Nov 4, 9:26 PM
$BTMD Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.01 down -95.45% YoY • Reported revenue of $43.33M down -9.65% YoY • Biote maintained 2026 guidance for revenue above $175M and Adjusted EBITDA above $25M; full-year dietary supplements revenue is expected to grow at a mid- to high-single-digit rate from 2025.
0 replies
hitmongreen Oct 23, 6:38 PM
$BTMD buying
0 replies
Chantal1 Oct 22, 7:40 PM
$BTMD Operates through healthcare practitioners who offer hormone optimization services. If the company restores product availability and strengthens practitioner productivity, procedure revenue could recover. Management expects sequential improvement in the second half of 2026.^^
0 replies
MyFriendsCallMeMoe Oct 21, 2:17 PM
$BTMD In goes another 10k
0 replies